An amicus brief regarding Abigail Alliance v. FDA.

This study finds that contingent fees benefit plaintiffs and do not cause higher awards.

Critics of the U.S. tort system often argue that the contingency fee system provides incentives for excessive litigation. Many of the criticisms and suggested policy reforms are based, however, on anecdotal evidence, rather than on systematic study of the contingency fee system. While capping contingency fees is still one...

A new book from the AEI Press finds that contingent fees benefit plaintiffs and do not cause higher awards.

Online registration for this event is closed. Walk-in registrations will be accepted.

In the past three decades, a mounting wave of litigation has swept the United States, prompting Newsweek to describe America as “lawsuit hell.” Fear of litigation has reduced innovation, menaced the health-care industry, driven manufacturers out of lawsuit-prone specialties,...